Mectizan Donation Program

08/31/2026

08/31/2026

08/28/2026

Eliminating is within reach in Africa, but sustaining progress requires continued investment and collaboration.

During , health leaders & partners are explored ways to protect hard won gains and accelerate implementation of the WHO road map for the year 2021–2030.

08/25/2026

Out now: MDP Highlights of 2025 📣 In January Niger was verified as the first country in Africa to eliminate the transmission of river blindness, an incredible milestone that was reached through vector control and annual mass distribution of Mectizan with sustained high treatment coverage. This breakthrough was once thought impossible. Learn more in our Annual Highlights publication online: https://mectizan.org/news_resources/2025-mectizan-donation-program-annual-highlights/

08/20/2026

🦟 When you think of mosquito-borne diseases, is your first thought malaria? Mosquitoes also transmit lymphatic filariasis, which is called a “neglected” tropical disease because it doesn’t get as much global attention, even though hundreds of millions remain threatened by it.

On World Mosquito Day, we’re bringing that attention to LF and to the governments, health workers, and volunteers working to eliminate LF across Africa.

08/18/2026

Tchad, actualités Tchad, info Tchad, news Tchad, Tchad, actualités Tchad, info Tchad, news Tchad

08/18/2026

Out now: MDP Highlights of 2025 📣 In November Merck announced an extension of its donation of up to 100 million Mectizan treatments annually through 2030 for the global fight against lymphatic filariasis. Learn more in the Annual Highlights publication online: https://mectizan.org/news_resources/2025-mectizan-donation-program-annual-highlights/

08/12/2026

08/11/2026

Out now: MDP Highlights of 2025 📣 The Mectizan Donation Program reached a tremendous milestone in 2025—five billion Mectizan treatments donated since 1988 to eliminate river blindness and lymphatic filariasis. We celebrated throughout the year with partners across the globe. See photos here: https://mectizan.org/news_resources/2025-mectizan-donation-program-annual-highlights/

08/10/2026

Timor-Leste made history when it was validated by World Health Organization (WHO) for eliminating lymphatic filariasis (LF) as a public health problem, becoming the first country to achieve this using a "triple therapy" treatment strategy.

Highlighted in our latest annual report, this landmark milestone safeguards 1.4 million people from permanent disability. The achievement was driven by strong leadership and dedication from the Ministry of Health, local health workers, and with donated medicines from Merck, GSK, and Eisai Global. The Task Force’s Mectizan Donation Program manages Mectizan donations and coordinates delivery of GSK’s albendazole.

Timor-Leste’s success is already paving the way for other nations fighting LF. Read the full story in our annual report: https://www.taskforce.org/2025-annual-report/freeing-future-generations-from-lf/